Public CbCR Disclosure (EU Directive)

Public CbCR Disclosure (EU Directive)

Section 1. General information

Name of ultimate parent of group / of standalone company	Almac Group Limited
Country of registered office of ultimate parent undertaking	The United Kingdom of Great Britain and Northern Ireland
Date of start of financial year	2024-10-01
Date of end of financial year	2025-09-30
Reporting currency	GBP
Application of option to report in accordance with taxation reporting instructions	true
Name and registered office of a single subsidiary undertaking which has published the report on income tax information of an undertaking that is not governed by the law of a Member State	Almac Pharmaceuticals Group (Ireland) Limited
Name and address of a single branch which has published the report on income tax information of an undertaking that is not governed by the law of a Member State	N/A

Section 2. Overview of information on a country-by-country basis

Jurisdiction	Country code	Revenues	Profit Before Tax	Tax Accrued	Tax Paid	Accum. Earnings	Employees
Denmark	DK	2017491	126718	32637	9010	0	0
Germany	DE	2131251	118498	0	0	-178850	5
Ireland	IE	75311160	13259029	1467046	889990	84309121	396
Netherlands	NL	228269	64129	0	0	-604442	0
Sweden	SE	8899833	-5577	0	-33345	1878895	12
All other tax jurisdictions (aggregated basis)
		1470483143	92835416	23301145	12387453	406354021	7062

Section 3. List of subsidiaries and activities

Name of Member State or tax jurisdiction	Country code of Member State or tax jurisdiction	Name of subsidiary undertakings consolidated in financial statements of ultimate parent undertaking	Brief description per country of nature of activities in Member State or tax jurisdiction
Denmark	DK	POA Pharma Scandinavia AB	Sales, marketing or distribution
Germany	DE	POA Pharma GmbH	Sales, marketing or distribution
Ireland	IE	Almac Pharmaceuticals Group (Ireland) Limited	Holding shares or other equity instruments
Ireland	IE	Almac Sciences (Ireland) Limited	Provision of services to unrelated parties
Ireland	IE	Almac Clinical Services (Ireland) Limited	Provision of services to unrelated parties
Ireland	IE	Almac Pharma Services (Ireland) Limited	Provision of services to unrelated parties
Ireland	IE	Almac Diagnostic Services (Ireland) Limited	Dormant
Ireland	IE	Arran Chemical Company Limited	Provision of services to unrelated parties
Ireland	IE	Camla (No1) Pharma Ireland Limited	Dormant
Ireland	IE	BioClin Research Laboratories Limited	Dormant
Ireland	IE	Galen Pharma Ireland Limited	Dormant
Ireland	IE	InterGal Pharma Ireland Limited	Dormant
Netherlands	NL	Your Research Holdings B.V.	Holding shares or other equity instruments
Netherlands	NL	Your Research Software B.V.	Holding or managing intellectual property
Netherlands	NL	Your Research B.V.	Provision of services to unrelated parties
Netherlands	NL	Almac Clinical Technologies LLC (branch)	Administrative, management or support services
Sweden	SE	POA Pharma Scandinavia AB	Sales, marketing or distribution

Section 4. Omitted information

Information omitted (if any) for this financial year
Information omitted	Information omitted, other tax jurisdictions	Explanation of reason for omission of information
N/A	N/A	N/A
Disclosure of information omitted for previous financial years
N/A

Section 5. Explanation of any material discrepancies between income tax paid and accrued

Explanation of any material discrepancies between income tax paid and accrued
N/A